feed,title,long_url,short_url
GN:S:RL,Small molecule targeting CD47-SIRPÎ± pathway: Insilico Medicine achieves its first major milestone in Fosun Pharma collaboration with the nomination of preclinical candidate for QPCTL - EurekAlert,https://www.eurekalert.org/news-releases/943958,https://bit.ly/34QjdQc
